ASSURE Wearable ECG vs HealthCCSng
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you require continuous, real-time heart rate monitoring and immediate alerts for at-risk cardiac patients. This tool is ideal for managing patients who need ongoing surveillance for arrhythmias or post-event monitoring, providing clinicians with actionable trend data and automatic episode storage for timely intervention.
View ASSURE Wearable ECG →Choose HealthCCSng if…
Choose HealthCCSng if your primary goal is to automatically detect and quantify coronary artery calcification from routine CT scans to assess a patient's risk of coronary artery disease. This solution is best suited for identifying asymptomatic individuals at risk or for population health initiatives where efficient, automated cardiac risk stratification from existing imaging data is desired.
View HealthCCSng →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | HealthCCSng |
|---|---|---|
| Pricing | Unknown | Not publicly available |
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Cloud-based, integrates with PACS and EMR systems |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieTool A focuses on patient usability with its comfortable SensorFit Garment and mobile application for monitoring and interaction. Tool B emphasizes clinician usability through seamless integration with existing PACS and EMR systems, streamlining workflow without human intervention. Both prioritize ease of use but for different primary users and interaction points.
Clinical Value
TieTool A provides continuous, real-time heart rate monitoring and trend data for at-risk cardiac patients, aiding in early detection and ongoing management with its advanced artifact filtering. Tool B offers automated detection and quantification of coronary artery calcification from routine CT scans, providing crucial risk stratification for coronary artery disease by leveraging existing imaging data. Both deliver significant, yet distinct, clinical value in cardiac care.
Pricing & Value
TieBoth Tool A and Tool B state that pricing information is not publicly available and requires direct contact with the vendor. Without transparent pricing details or specific value-based outcomes, it is impossible to conduct a head-to-head comparison on this dimension.
Enterprise Readiness
HealthCCSngWhile both tools are FDA-cleared, HIPAA compliant, and utilize cloud platforms, Tool B explicitly highlights 'Seamless integration with PACS and EMR systems'. This direct integration into core hospital IT infrastructure demonstrates a more established and critical pathway for enterprise adoption within radiology workflows compared to Tool A's general cloud-based clinician review platform.
Innovation
TieTool A demonstrates innovation through its advanced wearable technology, including the SensorFit Garment and Adaptive Patient Intelligenceu2122 for superior ECG monitoring and artifact reduction. Tool B innovates by applying AI to opportunistically analyze routine, non-gated CT scans for CAC detection, extracting new clinical value from existing imaging data. Both represent significant advancements in their respective domains within cardiology.
Support & Docs
ASSURE Wearable ECGTool A offers a more transparent and comprehensive support structure, including a dedicated helpline, patient service representatives for training, and a range of publicly available patient and provider documentation such as user manuals, handbooks, and setup videos. Tool B, while implying support through seamless integration, does not provide specific details on ongoing support channels or extensive public documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | HealthCCSng |
|---|---|---|
| Name | ASSURE Wearable ECG | HealthCCSng |
| Company | Kestra Medical Technologies | Nano-X AI |
| Description | A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. | An FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI |
| Specialties | Cardiology | Cardiology, Radiology |
| Key Features | Wearable ECG device for continuous heart rate monitoring, SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts, Automatic episode storage, Alert-based notifications, Physiologic trend data, Kestra CareStation remote patient data platform for clinician review | Analyzes non-contrast, non-ECG gated chest CT scans, Automatically detects and quantifies coronary artery calcification (CAC), Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, Generates a numerical calcium score, Provides visualization of calcified plaques within coronary arteries, Seamless integration with PACS and EMR systems, Automated workflow for results without human intervention, Customizable CAC category configuration |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and HealthCCSng.